Labcorp nets companion diagnostic approval for Pfizer's hemophilia B gene therapy Beqvez
The FDA approved its first gene therapy companion diagnostic test last June, developed through a collaboration between ARUP Laboatories and BioMarin, maker of the hemophilia A treatment Roctavian (valoctocogene roxaparvovec-rvox).